PET in vivo generators 134Ce and 140Nd on an internalizing monoclonal antibody probe

[1]  F. M. Nortier,et al.  Developing the 134Ce and 134La pair as companion positron emission tomography diagnostic isotopes for 225Ac and 227Th radiotherapeutics , 2020, Nature Chemistry.

[2]  T. Stora,et al.  Chemical Purification of Terbium-155 from Pseudo-Isobaric Impurities in a Mass Separated Source Produced at CERN , 2019, Scientific Reports.

[3]  C. H. Nielsen,et al.  Neodymium-140 DOTA-LM3: Evaluation of an In Vivo Generator for PET with a Non-Internalizing Vector , 2017, Front. Med..

[4]  A. Kjær,et al.  In Vivo Radionuclide Generators for Diagnostics and Therapy , 2016, Bioinorganic chemistry and applications.

[5]  B. Ross,et al.  Antibody-based PET of uPA/uPAR signaling with broad applicability for cancer imaging , 2016, Oncotarget.

[6]  Osman Ratib,et al.  [CERN-MEDICIS (Medical Isotopes Collected from ISOLDE): a new facility]. , 2014, Revue medicale suisse.

[7]  E. Lengyel,et al.  Urokinase Plasminogen Activator System–Targeted Delivery of Nanobins as a Novel Ovarian Cancer Therapy , 2013, Molecular Cancer Therapeutics.

[8]  T. O’Halloran,et al.  The Many Spaces of uPAR: Delivery of Theranostic Agents and Nanobins to Multiple Tumor Compartments through a Single Target , 2013, Theranostics.

[9]  T. O’Halloran,et al.  Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic. , 2011, Current pharmaceutical design.

[10]  M. Lubberink,et al.  Production, PET performance and dosimetric considerations of 134Ce/134La, an Auger electron and positron-emitting generator for radionuclide therapy. , 2002, Physics in medicine and biology.

[11]  D. Scheinberg,et al.  Tumor Therapy with Targeted Atomic Nanogenerators , 2001, Science.

[12]  S. Jurisson,et al.  Development of an in vitro model for assessing the in vivo stability of lanthanide chelates. , 2001, Nuclear medicine and biology.

[13]  G. J. Beyer,et al.  Radioactive ion beams for biomedical research and nuclear medical application , 2000 .

[14]  F. Rösch,et al.  A 140Nd/140Pr radionuclide generator based on physico-chemical transitions in 140Pr complexes after electron capture decay of 140Nd-DOTA , 2007 .

[15]  Eva Forssell-Aronsson,et al.  Radiolanthanides in nuclear medicine. , 2004, Metal ions in biological systems.

[16]  U. Köster,et al.  ISOLDE target and ion source chemistry , 2001 .